creatine monohydrate: Clinical Trials

9 trials of creatine monohydrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 1 terminated, 1 unknown. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Recruiting 2, Terminated 1, Unknown 1
Phase 21Completed 1

Follow creatine monohydrate: new trials by email Literature Review of creatine monohydrate trials Research Report on creatine monohydrate

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
creatine monohydrate, Placebo, Home-based, telehealth - Metastatic Prostate Cancer
Phase 3RecruitingUniversity of Utah2002023-11-092026-06-03
A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
Creatine monohydrate, Placebo - Major Depressive Disorder
Phase 3CompletedUniversity of Utah182020-08-032024-11-26
Creatine for Depressed Male and Female Methamphetamine Users
Creatine monohydrate - Depression, Anxiety
Phase 3RecruitingMontana State University292015-11-012015-12-11
Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone
creatine monohydrate, sugar placebo - Osteoporosis, Sarcopenia
Phase 3CompletedUniversity of Saskatchewan902010-01-012012-12-27
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Creatine Monohydrate, Placebo - Huntington's Disease
Phase 3TerminatedMassachusetts General Hospital5532009-09-012016-03-11
Creatine in Treating Patients With Cancer-Associated Weight Loss
creatine monohydrate, placebo - Anorexia, Cachexia
Phase 3CompletedAlliance for Clinical Trials in Oncology3002004-12-012020-04-29
Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Creatine Monohydrate - Amyotrophic Lateral Sclerosis (ALS)
Phase 3UnknownThe Avicena Group1072003-06-012005-06-24
Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy
Creatine Monohydrate, Glutamine - Muscular Dystrophy, Duchenne
Phase 2 / Phase 3CompletedCooperative International Neuromuscular Research Group482000-06-012011-10-27
A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)
glutamine, creatine monohydrate - Muscular Dystrophy, Duchenne
Phase 3CompletedNational Center for Research Resources (NCRR)2005-06-24

Conditions studied

Muscular Dystrophy, Duchenne (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anorexia (1)  ·  Anxiety Disorders (1)  ·  Body Weight Changes (1)  ·  Cachexia (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Huntington Disease (1)  ·  Mitochondrial Diseases (1)  ·  Osteoporosis (1)  ·  Prostatic Neoplasms (1)  ·  Sarcopenia (1)

Sponsors

University of Utah (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Cooperative International Neuromuscular Research Group (1)  ·  Massachusetts General Hospital (1)  ·  Montana State University (1)  ·  National Center for Research Resources (NCRR) (1)  ·  The Avicena Group (1)  ·  University of Saskatchewan (1)

Countries

United States (8)  ·  Canada (2)  ·  Australia (1)  ·  New Zealand (1)

Top investigators

Adriana Coletta, PhD, MS, RD (1)  ·  Aminah Jatoi, MD (1)  ·  Darren Candow, Ph.D. (1)  ·  Diana M Escolar, MD (1)  ·  Diana Rosas, MD, MS (1)  ·  Giovanni Schifitto, MD (1)  ·  Gunnar Buyse, MD, PhD (1)  ·  Philip Chilibeck, Ph.D. (1)  ·  Rosenfeld Jeffrey, MD (1)  ·  Steven M Hersch, MD, PhD (1)  ·  Tracy Hellem, PhD (1)

Results publications

PMID 15984021, PMID 28701493, PMID 30103342, PMID 34107512, PMID 35747889, PMID 38637770

NIH funding

R01CA281759 (1), U01AT000613 (1)